Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Current Leases: 2019-2025

Historic Current Leases for Assembly Biosciences (ASMB) over the last 7 years, with Sep 2025 value amounting to $548,000.

  • Assembly Biosciences' Current Leases fell 58.77% to $548,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $548,000, marking a year-over-year decrease of 58.77%. This contributed to the annual value of $461,000 for FY2024, which is 62.21% down from last year.
  • As of Q3 2025, Assembly Biosciences' Current Leases stood at $548,000, which was up 2.81% from $533,000 recorded in Q2 2025.
  • In the past 5 years, Assembly Biosciences' Current Leases registered a high of $3.4 million during Q3 2022, and its lowest value of $461,000 during Q4 2024.
  • Its 3-year average for Current Leases is $1.1 million, with a median of $1.1 million in 2024.
  • Its Current Leases has fluctuated over the past 5 years, first slumped by 74.22% in 2023, then skyrocketed by 52.93% in 2024.
  • Over the past 5 years, Assembly Biosciences' Current Leases (Quarterly) stood at $3.2 million in 2021, then rose by 6.76% to $3.4 million in 2022, then plummeted by 63.73% to $1.2 million in 2023, then crashed by 62.21% to $461,000 in 2024, then crashed by 58.77% to $548,000 in 2025.
  • Its last three reported values are $548,000 in Q3 2025, $533,000 for Q2 2025, and $529,000 during Q1 2025.